IT Advisory Board
John Stone
William A. Bautz
Robert Charette, Ph.D.
David Linthicum
William Ruh
Scott L. Kauffman

Life Sciences Advisory Board
Ronald Burch, MD, Ph.D
Abraham Abuchowski PhD
Adam Gazzaley, MD, Ph.D
Shawn Zimberg, MD
John Aitchison, Ph.D
Barry W. Feig, MD
Brian D. Sklar, MD
Howard Martin Fillit, MD

Mr. Taub has over 10 years of entrepreneurial experience in the operations and development arena working with start-up companies. He has developed and managed sales and marketing operations teams within the software, hardware, financial, real estate and internet industries.

Prior to joining Foundation Ventures, Mr. Taub was Co-Founder and Managing Director of ApartmentZone, which was developed to consolidate and upgrade the real estate brokerage industry using technology, communications and the Internet. He played an instrumental role in software development, business development and operations infrastructure. Mr. Taub has also held various positions at Encyclopedia Britannica and Zacks Financial Research.

Jonathan York was previously an independent healthcare consultant advising early stage companies in the area of corporate strategy and financial service firms on their life science portfolios. Dr. York has extensive clinical and management experience in healthcare; he was the Founder and former President and CEO of Long Island Emergency Care, a professional services firm that provides physician and physician extender support to a major Trauma Center.

Dr. York received his undergraduate degree in the biological sciences from the University of Pennsylvania. He received his M.D. from the Boston University School of Medicine and completed residency training in both Internal Medicine and Emergency Medicine at the Albert Einstein College of Medicine in New York. He is Board Certified in Internal Medicine and Emergency Medicine and is a Fellow of the American College of Emergency Physicians. He has served as an oral examiner for the American Board of Emergency Medicine. Dr. York has been a frequent lecturer and author on topics in the field of Emergency Medicine.

He holds an M.B.A. in Finance and Management from the Stern School at New York University where he was a winner of the school's corporate strategy competition.

Dr. Neches is one of America's leading technologists. He was Founder and Chief Scientist of Teradata Corp (1979-1988). Teradata pioneered the application of parallel processing to commercial applications with hardware and software products that implement the world's largest relational databases. The company raised $70 MM through venture capital and public financings and was subsequently acquired by AT&T for a return to shareholders of over $1 billion. The company is now part of NCR Corporation.

As Senior Vice President and Chief Scientist of NCR, Dr. Neches led the repositioning of the entire computer product family prior to merger with AT&T and then led product plan for merger with AT&T. During this period, he was on the Board of Directors of MCC and Semitech (research consortiums) and Dayton Public Radio. He became Vice President and Chief Technical Officer, Multimedia Products and Services Group, AT&T Corp., where his responsibilities included microelectronics, data communication products, business telephone products (including call centers), consumer products, and initial incubation of what became AT&T’s Internet service.

Dr. Neches serves on the Board of Directors of PeopleLink Corporation and ExpandBeyond Inc. His prior directorships include DemoGraFx, MediaMap, and VendQuest. He serves on the Advisory Board of EarthLink, Tacoda Systems, Luxtera, and the Technology Group (analyst practice) for Merrill Lynch. In 1999, Dr. Neches served as Acting Chief Technology Officer of idealab! (an Internet B2C company incubator).

Dr. Neches received his formal training at the California Institute of Technology, where he holds a B.S. (1973), M.S. (1977), and Ph.D. (1983) in Computer Science. Dr. Neches serves on Caltech’s Board of Trustees, sits on its Audit, Investment, Business & Finance, Development, JPL, and Executive Committees, and chairs the Technology Transfer Committee.

Mr. Bautz is the President of WAB Consulting. His clients include The New York Stock Exchange, for design of Global Equity Market (GEM) to enable 24-hour equity trading among multiple international stock exchanges and an in depth study of pricing alternatives to more directly reflect the cost of using specific NYSE services. He has also worked with Bolsa de Valores de Lisboa e Oporto (BVLP), where he studied current systems technology and organization and led a discussion with the Board of Directors on strategic options. At MobileHelix, Inc., a wireless software product developer, Mr. Bautz is a member of the Advisory Board of this. His is also a technical Advisor for MarketConnex, Inc. in the development of a retail equity order management and routing system for the international market.

Prior to this, Mr. Bautz served as Senior Vice President and CTO of the New York Stock Exchange, where his responsibilities included development of trading and regulatory systems solutions as well as the technologies that supported NYSE’s day-to-day operations. While at NYSE, he implemented a wireless data network and hand held terminal system providing seamless messaging and order management to Floor Brokers anyplace on the NYSE floor – a key component of allowing improved access to the point of sale, improving trade execution time and quality. Mr. Bautz implemented systems upgrades leading to improvements in specialist order processing, enhanced trade comparison rates and increased systems capacity, allowing the NYSE to cope with enormous growth in equity trading volumes, successfully transition to Y2K and prepare for decimal trading.

Prior to the NYSE, Mr. Bautz was Managing Director of Global Systems at American Express, where he was responsible for the design, implementation and operation of all the systems that supported the Bank throughout the world. At American Express, he built a single, lean and efficient Global Systems organization, and consolidated 18 individual country-based data processing operations into regional centers in New York, Singapore and Poole, U.K. He re-directed the Bank's technical strategy to implement short-term system solutions delivering immediate operational improvements and savings, and implemented a single global SWIFT interface system used by 23 countries. Mr. Bautz worked on systems for Letters of Credit, Electronic Banking, Derivatives, F/X Dealing and Settlement, Global Margin Trading, Data Warehousing and Integrated Client Service.

At Shearson Lehman Brothers, Mr. Bautz was responsible for company-wide global systems development, managing staff growth from 100 to over 800 systems developers. Mr. Bautz designed, developed and implemented global systems supporting one of the largest U. S. stock brokerage, trading and investment banking firms. He designed, developed and installed Shearson Financial Management Account (FMA), the first account of its type which used the American Express Card. Mr. Bautz achieved integration of check, mutual fund, credit card and securities processing, and designed a new Shearson Client Statement. He designed, developed and installed the Trading Management System (TMS) and Shearson Securities System (SSS). These multi-year projects automated all aspects of order entry, trade execution and back office processing. He established the London Systems Development Organization and Data Center, and implemented trading systems in preparation for the "Big Bang".

With over 28 years of experience in a wide variety of software, systems and management positions, Dr. Charette is an internationally acknowledged authority in information systems and technology, systems engineering, risk management, the lean development and management of large-scale software-intensive systems, and business entrepreneurship and innovation. He is best known for his unique integrated approach to business, financial and technical risk assessment, and management. Dr. Charette is the creator of the Cynic® Risk Management Methodology, the PROFIT Management System™, the Dynamic Risk Helix™, and the Eris™ Risk Analysis Method, among others.

He is the President of the ITABHI Corporation, an international high technology company specializing in information technology and telecommunications systems management consulting that he founded in 1987. He is also a Fellow of the Cutter Consortium and the Director of its Enterprise Risk Management and Governance Practice.

Dr. Charette serves as a senior advisor to a wide variety of international Fortune 100 companies and high tech consortiums, as well as government civil and military departments on the effectiveness, impacts, and rewards/risks of their information systems and other high-technology programs and policies. Clients have included Alcatel, BAe/Sema, Bell Canada, British Telecom, Bombardier, CSC, ExxonMobil, IBM, Lockheed Martin, NASA, NATO, Northrop Grumman, Office of the Secretary Defense, PacBell, Phillips, Raytheon, Rockwell Collins, Scotland Yard, U.K. Health Services Department, U.K. Social Security Department, U.K. Ministry of Defense, Unisys, U.S. Air Force, Army, Navy, and Washington Group International, among many others. Dr. Charette has also acted as a chief risk consultant to financial organizations and investment companies during private investment and merger and acquisition actions. Over his career, he has been involved in many dozens of risk assessments on projects and programs costing from several million to several billion dollars.

Dr. Charette has been involved in all aspects of business and technical risk management. For example, he was the chief designer of the DoD Tri-Service Assessment Initiative that assessed over 50 major UD DoD weapon systems, the working group chair of the new ISO risk management standard P16085, the past chair of IEEE Standard 1540-2001 on risk management, and is a founder and charter member of the Project Management Institute’s risk management special interest group (currently on its risk management advisory board). Charette served for many years as an expert advisor to the risk management programs at the U.S. Software Engineering Institute at Carnegie Mellon University (serving as chair of its Risk Advisory Board) and the U.S. Software Productivity Consortium, the Big 12 Universities’ Usenix computer security project, among others. Dr. Charette was the lead author of the business risk management guidelines now in use in the U.K. Government; served on the post-Challenger National Research Council’s Select Panel evaluating the effectiveness of the space shuttle’s software safety program, and is the former elected chair and vice-chair of the National Security Industrial Association's (NSIA) Software Committee. Dr. Charette also served on the executive board of several high-technology start-up companies.

Dr. Charette is an author and frequent international lecturer. He is the author of the classic books, Applications Strategies for Risk Management, Software Engineering Risk Analysis and Management, and Introduction to the Management of Risk, along with several others. Dr. Charette has written over 70 magazine, journal and other published articles, as well as contributed book chapters, on the subject of risk management, project management, and innovation and entrepreneurship. Dr. Charette was a long-time contributing editor to the London-based magazine Software Management, and is currently on the editorial board of Software Quality Professional. Dr. Charette is often sought by newspapers and television such as CNN, the Wall Street Journal, the Boston Globe and Investors Business Daily for his insights into business risk issues.

Prior to ITABHI, Dr. Charette worked as an electronics engineer and project manager involving submarine sonar and combat systems at the U.S. Naval Underwater Systems Center, Newport, Rhode Island. After NUSC, he worked as a principal consultant for SofTech, Inc. in Newport, Rhode Island involving risk management of military logistics and weapon systems. Dr. Charette then worked as a senior member of the executive staff for Computer Sciences in London, England doing risk assessments for a variety of major U.K. government programs. He served in the U.S. Air Force’s Strategic Air Command as an avionics and electronic warfare specialist.

Dr. Charette's degrees are in electrical and computer systems engineering. He also has received training at the U.S. Naval War College and U.S. submarine school, as well as from the U.S. Army aviation, armor, artillery and infantry schools. Dr. Charette is a long-time member of the IEEE, ACM, Society of Risk Analysis, Risk Policy Institute, and the Academy of Political Science, among others. He is listed in Lexington’s Who’s Who Among Executives and Professionals and International’s Who’s Who of IT Professionals.

Mr. Linthicum is an internationally known application integration expert, having formed many of the ideas for modern distributed computing including EAI (Enterprise Application Integration) and B2B application integration, approaches and technology in wide use today.

Mr. Linthicum is currently the CTO of Grand Central Communications (www.grandcentral.com), where he sets technology strategy and leads thought in the industry. He is the former CTO of Mercator Software and has held key technology management roles with a number of organizations including CTO of SAGA Software, Mobil Oil, EDS, AT&T, and Ernst & Young. He was also an Associate Professor of Computer Science, and continues to lecture at major technical colleges and universities. Mr. Linthicum keynotes at many technology conferences including eB2B Marketplace World, eB2B World, Software Development, eBusiness World, EAI Summit, B2B Application Integration Summit, Enterprise Integration, e-Business Integration, Computing Without Bounds, iEC, iEB, and Comdex.

Mr. Linthicum has authored over 350 articles for major computing publications, and has monthly columns in several popular industry magazines. He has authored or co-authored six books including David Linthicum's Guide to Client/Server and Intranet Development, and the best-selling Enterprise Application Integration released in 1999. His latest book, Next Generation Application Integration, was just released and is already a best seller.

Mr. Linthicum serves as an established member of many standards bodies including W3C, OAG, RosettaNet, OASIS, and the OMG. He also is an advisor to high tech companies such as Bondmart.com, Avanki, and WebV2.

William Ruh has more than 20 years of industry experience and expertise in enterprise application integration and object technology. He was the Chief Technology Officer for Software AG, Inc. In addition, Mr. Ruh was responsible for the growth and expansion of the Solutions and Consulting Services team to provide Software AG's customers with superior customized and industry-specific solutions.

Prior to joining Software AG, Inc., Mr. Ruh was Chief Technology Officer at The Advisory Board, a company that provides research into healthcare related best practices. Additionally, he served as Executive Vice President and CTO at Concept Five Technologies and acted as various executive-level technology and professional services positions at The MITRE Corporation.

Mr. Ruh graduated with a B.S. and M.S. in computer science from California State University, Fullerton. His latest book is Enterprise Integration, released in July 2004 by Addison Wesley. His other books are Enterprise Application Integration released in 2000 by John Wiley & Sons, Inc, Inside CORBA: Distributed Object Standards and Applications, released in 1997, and IIOP Complete: Middleware Interoperability and Standards released in September 1999 by Addison-Wesley.

Scott has deep experience in traditional and online publishing along with advertising, digital media and Web technology. He joins BlueLithium from Zinio, a pioneer in digital publishing and marketing services, which he has led since 2004. Scott's background includes leadership positions at CompuServe and Time Warner, where he served on the founding team of Entertainment Weekly magazine and as vice president of business development for Time Warner Interactive. At CompuServe, he was responsible for all consumer businesses and was a member of the road show team for the company's 1996 initial public offering. Prior to Time Warner, he was also a publisher and general manager at Newsweek. Scott was recruited to Silicon Valley in 1997 by Kleiner Perkins to become president & CEO of AdKnowledge, which was founded by Dave Zinman who is currently senior vice president of products for BlueLithium. After selling AdKnowledge to CMGI in 1999, Scott ran eCoverage (direct-to-consumer insurance), MusicNow (online music service) and Coremetrics, a leader in web analytics, where he remains a member of the Board of Directors. He was honored by Advertising Age in 1996 as one of twenty Digital Media Masters. In July of 1992, Advertising Age named him one of the top 100 marketers in the country.

Abraham Abuchowski, Ph.D. is Founder and CEO of Prolong Pharmaceuticals. Dr. Abuchowski was the founder and past Chairman and CEO of Enzon, Inc., a multi-billion dollar biopharmaceutical company that specializes in PEGylation technology. During his 13 years at Enzon (1983-1996), Dr. Abuchowski successfully commercialized PEGylation by gaining FDA approval for three protein-based biopharmaceuticals. Dr. Abuchowski was instrumental in helping Enzon mature from a developmental stage company to a fully integrated publicly traded biopharmaceutical company.

Dr. Abuchowski holds a B.S. and a Ph.D. in Biochemistry from Rutgers University. He is an internationally recognized authority on biopharmaceutical delivery and has published more than 100 scientific papers and several book chapters on therapeutic products. In 1994, Dr Abuchowski founded and served as the first Chairman of the Biotechnology Council of New Jersey. Dr. Abuchowski is one of New Jersey’s top entrepreneurs and is recognized at both the state and national levels as an outstanding bioscience executive. In 1990, Dr. Abuchowski was named New Jersey's "Entrepreneur of the Year" for high-technology, awarded by Ernst & Young, Inc. Magazine, and Merrill Lynch.

In 1990, Dr. Abuchowski was named Entrepreneur Business Leader of the Year by New Jersey Monthly. In 1991, the National Organization for Rare Disorders awarded him with their Corporate Leadership Award for outstanding commitment to orphan drug development and making enzyme replacement therapy a reality. Additionally, in 1993, he won the Public Health Service Award for Exceptional Achievements in Orphan Products Development. In November of 1993, he received the Triumphs Through Technology Award from the Los Angeles Chapter of the Leukemia Society of America.

In 2001, Dr. Abuchowski was listed as one of the "Top 50" graduates of Rutgers College of Arts and Sciences and in 2002 was inducted into the Rutgers Hall of Distinguished Alumni.

Dr. Gazzaley is a world-renown neuroscientist focusing on cognition and memory in aging. He has published numerous articles and abstracts in peer-reviewed journals including Proceedings of the National Academy of Sciences, Journal of Neuroscience, Nature Neuroscience Reviews, Experimental Neurology and Neurobiology of Aging. He has lectured extensively on neural networks, aging (specifically on Alzheimer’s), and top-down modulation in visual processing.

Dr. Gazzaley received his M.D. and Ph.D. degrees from the Mt. Sinai School of Medicine in New York City. He completed his residency in Neurology at the Hospital of the University of Pennsylvania, and is currently Assistant Professor of Neurology and Physiology at the University of California, San Francisco (UCSF) and a faculty member of the Neuroscience Graduate Program. He was awarded and conducted research under an American Federation for Aging Research post-doctoral grant and a National Research Service Award post-doctoral grant. He was awarded the Cajal Club’s prestigious KriegCortical Scholar Award for his doctoral thesis entitled: Glutamate Receptor Plasticity in the Hippocampus: Implications for Age-Related Learning and Memory Deficits.

Dr. Gazzaley is Board Certified in Neurology, and is a member of several Neurology and Neuroscience societies including the American Academy of Neurology, Cognitive Neuroscience Society, the Organization for Human Brain Mapping and the Society for Behavioral and Cognitive Neurology. He is a contributing editor to Science’s Science of Aging Knowledge Environment.

Dr. Zimberg is a board-certified Radiation Oncologist with experience in both clinical oncology and life-science/medical technology sector investing.

Dr. Zimberg is in clinical practice at Radiation Oncology Associates of Long Island. He is recognized as a leader in the treatment of prostate, breast and head & neck cancers. He routinely lectures to patients and fellow physicians on radiation-based technologies for cancer treatment. He has been an invited guest faculty member at MD Anderson Cancer Center’s annual Updates and Controversies in Oncology conference, speaking on head & neck cancer and brain tumors.

Prior to completing his residency at Memorial Sloan-Kettering Cancer Center, Dr. Zimberg was a medical advisor to Advanced Capital Resources, a private banking concern, where he specialized in medical device and biotechnology sectors. Dr. Zimberg received his undergraduate and M.D. degrees from the University of Michigan, Ann Arbor. As a resident at Memorial Sloan-Kettering Cancer Center, he was awarded an American Cancer Society sponsored clinical oncology fellowship. More recently, he was the recipient of the American Cancer Society's Cancer Control Award, and currently serves as the Medical Spokesman for the American Cancer Society’s Eastern Division Advisory Board.

Since September 2000, Dr. Aitchison has been a faculty member of the Institute for Systems Biology in Seattle, Washington (www.systemsbiology.com). His laboratory and research focus on applying systems approaches to the study of fundamental cell biology via an integration of traditional science with new high-throughput technologies and computational biology to bring about an understanding of how the three-dimensional architecture of cells imparts control over cellular function. He has vast experience in functional genomics, proteomics, and genetics.

Dr. Aitchison received his Ph.D. in 1992 from McMaster University in Ontario, Canada in biochemistry, specializing in biotechnology and genetic engineering, working in the laboratory of Richard Rachubinski on the molecular mechanisms responsible for sorting proteins into peroxisomes. From 1992-1997, Dr. Aitchison performed his postdoctoral work in the laboratory of Nobel Laureate Günter Blobel, where he applied classic cell biology techniques and yeast genetics in the study of protein import into the nucleus. He continued his work using large-scale proteomics as an Assistant Professor in the Faculty of Medicine and Dentistry at the University of Alberta from 1997-2000. He is currently an Associate Professor at the Institute for Systems Biology and holds Adjunct Associate Professorships at the University of Alberta and the University of British Columbia.

Dr. Feig is an internationally recognized surgical oncologist. He is currently an Associate Professor in the Department of Surgical Oncology at The University of Texas, MD Anderson Cancer Center in Houston, Texas, and holds a joint appointment in the Departments of Anesthesiology and Critical Care. His expertise and research interests include sarcoma and malignancies of the breast and gastrointestinal tract, as well as pioneering leading-edge surgical techniques including sentinel-node mapping. He has been affiliated with the MD Anderson Cancer Center since 1991 where, among other positions, he is currently the Chairperson of the Clinical Research Committee and a member of the Clinical Research Advisory Committee. Dr. Feig is the Chairperson of the South Texas Chapter of the American College of Surgeons’ Cancer Liaison Program, and serves on their Commission on Cancer. He has received numerous honors and awards, and in 2004 was again listed in the 4th edition of America’s Top Doctors.

As a leader in oncologic research, he has authored or co-authored over 100 publications in peer-reviewed journals, and has been the lead or co-author of many textbook chapters spanning all disciplines of oncology. As an academician, Dr. Feig has been the Principal Investigator of numerous NCI-funded collaborative oncology group trials. He has been the recipient of several research grants including “Human Cancer Gene Prevention and Therapy Allocation” and has recently been awarded over $150,000 for his work in evaluating the use of Fibrin Tissue Adhesive following axillary node dissections in patients with melanoma and breast cancer, and for sarcoma-related research.

Dr. Feig received his undergraduate degree from Colgate University and his medical degree from the State University of New York Health Science Center in Syracuse, New York. Following a Residency in General Surgery and a Research Fellowship at Northwestern University Medical School, Dr. Feig went on to complete a Trauma Fellowship at the University of Minnesota Hospitals and a Surgical Oncology Fellowship at UT MD Anderson Cancer Center. Dr. Feig is a Fellow of the American College of Surgeons.

Dr. Sklar is a board-certified obstetrician and gynecologist in a large clinical practice in suburban Chicago. For over ten years, he has been recognized as a leader in the treatment of a wide variety of problems in women's health including low and high-risk obstetrics, preventative medicine, contraception, infertility, pelvic pain, routine gynecology, urinary incontinence, menopausal medicine and gynecologic surgery. He is a fellow of the American College of Obstetricians and Gynecologists, and he serves as an active participant in multiple local and regional quality assurance and peer review committees.

Dr. Sklar received his undergraduate degree from the University of Michigan, Ann Arbor and his medical degree from Wayne State University in Detroit, Michigan. During his residency at Loyola University of Chicago, he conducted research on the impact of amniotic fluid on the latency to delivery of patients with preterm prematurely ruptured membranes. He has a strong interest in, and was recognized for excellence in student and resident medical education. More recently, Dr. Sklar has been working towards the development of processes and mechanisms to improve quality and efficiency in the hospital setting.

Howard Fillit, MD, a geriatrician and neuroscientist, is the founding Executive Director of the Institute for the Study of Aging, Inc. as well as its affiliated public charity the Alzheimer's Drug Discovery Foundation, both of which are dedicated to funding drug discovery for Alzheimer's disease. Dr. Fillit was formally the Corporate Medical Director for Medicare at NYLCare Health Plans (now a division of Aetna, Inc.), where he was responsible for over 125,000 Medicare members in 8 regional markets. He has also had a distinguished academic career at The Rockefeller University and The Mount Sinai Medical Center (NY), where he is currently a clinical professor of geriatrics and medicine and a professor of neurobiology. Dr. Fillit has received many awards and honors, including the Rita Hayworth Award for Lifetime Achievement from the Alzheimer's Association. He is a fellow of the American Geriatrics Society, the American College of Physicians, the Gerontological Society of America, and the New York Academy of Medicine. Dr. Fillit is the author or co-author of more than 250 publications, including the leading international Textbook of Geriatric Medicine and Gerontology. He served as a consultant to a variety of individuals, managed care organizations, health care systems, and pharmaceutical and biotechnology companies.

Richard Yacenda is a Managing Director and Chief Administrative Officer, Asia Pacific (ex Japan) for Deutsche Bank AG. In this capacity, Richard is responsible for the management and coordination of the firm’s governance platform across the business and the Legal, Compliance, Audit, Tax, CRES, Corporate Security, Company Secretariat and HR (Learning and Development) support functions. Richard is the Chairman of the Regional Real Estate and Asia Pacific Legal Entity Committee, and a member of the Regional Executive (EXCO), Operating, Infrastructure, Risk and Smart Sourcing Steering Committees.

Richard joined Deutsche Bank in April 2006 from JPMorgan in Hong Kong where he spent two years as a Managing Director holding the joint roles of Chief Administrative Officer for Asia Pacific and Chief Operating Officer for North Asia. As Chief Administrative Officer he was responsible for coordinating governance across many of the administrative areas and as Chief Operating Officer for North Asia the governance and coordination of the operations in Hong Kong, China, Taiwan, and South Korea. Prior to joining JP Morgan, Richard spent over 22 years at Goldman Sachs in Hong Kong and in New York. His most recent role at Goldman Sachs was Managing Director and Head of the Human Capital Management Division in Asia and was a member of the Goldman Sachs Asia Management Committee, the senior governance group for business governance, strategy and infrastructure.

Richard graduated form Fordham University in New York with a Bachelor of Science Degree in Accounting. He has resided in Hong Kong for over eight years.

Saul S. Cohen recently retired from his position as Corporate Department Partner of Proskauer Rose LLP, with extensive experience in securities regulation.

Mr. Cohen joined Proskauer in 1996 after serving as counsel for several well-known investment banking firms and previous law practices. At Proskauer, Mr. Cohen represented a broad list of securities firms throughout the nation.

Mr. Cohen has been General Counsel of Lehman Brothers Kuhn Loeb and A. G. Edwards & Sons and was the SEC-approved General Counsel of Drexel Burnham Lambert under Drexel's consent agreement with the S.E.C. Mr. Cohen also acted as Chapter 11 Trustee of Bevill, Bresler & Schulman Asset Management Corporation, a former government securities dealer, returning more than $100 million to creditors.

Mr. Cohen has been an Adjunct Professor of Law at Fordham University Law School where he has taught since 1983. He has served as Chairman of the Federal Regulation Committee of the Securities Industry Association and President of the SIA's Legal & Compliance Division. He has lectured and written widely on securities regulation subjects. His articles "The Death of Securities Regulation" appeared in The Wall Street Journal January 17, 1991; "De Modestes Propositions" in the French legal publication Actualite et Prospectives in October, 1992; "The Challenge of Derivatives" in the May, 1995 issue of the Fordham Law Review, "The Challenge of Derivatives (Continued)" in the December, 1997 issue of the Fordham Law Review and "Clearing the Air Over Clearing Firms" in The New York Times April 5, 1998, "The Deadly Coupling of Public and Inside Information in Wallstreetlawyer.com in October, 1997, "Keeping Track of News From Nowhere" in the Securities Industries News, in September 27, 1997, "NASD's "New' View of Netting Presents An Operational Nightmare in the Securities Industries News in October 12, 1998, "The Empire Strikes Back, Part I, The War Against Day Trading," in Wallstreetlawyer.com in May, 1999, "The Empire Strikes Back, Part II, The Empire's Inevitable Defeat" in Wallstreetlawyer.com in June, 1999, "Charles Schwab Is Latest Big Brokerage to Acquire a Day-Trading Firm" in E-Securities, in March, 2000, "Day Traders In Polite Society, Part I, The Clampetts Move to Nob Hill," in Wallstreetlawyer- .com in May, 2000; "Day Traders In Polite Society, Par II, The Clampetts Get a Trading License," in Wallstreetlawyer.com in June, 2000; �Does The SEC Focus On The Right Things?� in The Journal of Investment Compliance, Winter 2003; �It�s All In The Timing,� in Registered Rep magazine, January 2004. He also is Editor of Volumes 6, 6A, 6B and 6C, Securities Regulation Forms, Thomson West Group, (Spring 2004).

Mr. Cohen has served on the Board of Trustees of the Museum of Modern Art in New York, and as Vice-Chairman of the Board of Visitors of Columbia College and Chairman of its College Fund. He is President of the Rudolph W. Giuliani Center for Urban Leadership Inc.

Mr. Cohen received his undergraduate degree from Columbia University in 1957 and an L.L.B. from Yale Law School in 1960.

Mr. Sher is the Vice Chairman of the Board of Schostak Brothers & Company. Schostak Brothers is Michigan's largest full-service commercial and industrial realtor, specializing in shopping center development and management. Its restaurant division manages 68 restaurants in Michigan. Mr. Sher has been with Schostak Brothers & Company, Inc. since 1970. In addition to serving as Vice Chairman, he has served both as its Chief Financial Officer and Partner. Mr. Sher was involved with the overall financial management and the administration of the company.

Prior to Schostak Brothers, Mr. Sher was a partner in a CPA firm and has extensive experience in the practice of public accounting in the field of real estate. Mr. Sher is a Certified Public Accountant, an active real estate broker and formerly on the Board of Directors of both the Michigan Association of Certified Public Accountants and Providence Hospital. In addition, Mr. Sher is a management consultant with a focus primarily on the family-owned business arena and has been appointed an arbitrator by the American Arbitration Association. Mr. Sher has been a delegate from the Michigan Association of Certified Public Accountants to the National Future Forum working on the CPA �Vision� Project and is currently the Chair of the American Institute of Certified Public Accountants� Life Insurance Disability Plans Committee (AICPA) and is a former member of the AICPA's Council. Mr. Sher has also been appointed to the West Bloomfield Planning Commission and to the Michigan State Board of Accountancy for a term expiring in 2007. Mr. Sher also serves on the boards of numerous charitable organizations and has served as a guest lecturer at the University of Michigan Business School.